Rheumatoid arthritis: Evolving recognition of a common disease

被引:16
作者
Daikh, David, I [1 ,2 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] VA Portland Med Ctr, Portland, OR 97239 USA
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2022年 / 36卷 / 01期
关键词
Rheumatoid arthritis; Early arthritis; Immune pathogenesis; CYCLIC CITRULLINATED PEPTIDE; POLYMYALGIA-RHEUMATICA; AMERICAN-COLLEGE; ANTIBODIES; AUTOANTIBODIES; TARGET; ONSET; RECOMMENDATIONS; DETERMINANTS; SYMPTOMS;
D O I
10.1016/j.berh.2021.101740
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is a highly prevalent autoimmune dis-ease and the most common form of autoimmune inflammatory arthritis. Studies of RA pathogenesis have contributed significantly to understanding the basis for complex immune-mediated disease, identified key steps in the development of autoimmune activation and joint damage in RA, and led to the development of targeted therapies that opened up the era biologic therapy. Current studies are linking differences in gene expression to abnormalities in cellular function that will help optimize therapy for individual patients and advance the goal of personalized medicine. Our evolving understanding and current important issues in RA are highlighted.(c) 2021 Published by Elsevier Ltd.
引用
收藏
页数:5
相关论文
共 49 条
[1]   Anti-Citrullinated Peptide Antibody Assays and Their Role in the Diagnosis of Rheumatoid Arthritis [J].
Aggarwal, Rohit ;
Liao, Katherine ;
Nair, Raj ;
Ringold, Sarah ;
Costenbader, Karen H. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (11) :1472-1483
[2]   Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol [J].
Al-Laith, Mariam ;
Jasenecova, Marianna ;
Abraham, Sonya ;
Bosworth, Aisla ;
Bruce, Ian N. ;
Buckley, Christopher D. ;
Ciurtin, Coziana ;
D'Agostino, Maria-Antonietta ;
Emery, Paul ;
Gaston, Hill ;
Isaacs, John D. ;
Filer, Andrew ;
Fisher, Benjamin A. ;
Huizinga, Thomas W. J. ;
Ho, Pauline ;
Jacklin, Clare ;
Lempp, Heidi ;
McInnes, Iain B. ;
Pratt, Arthur G. ;
Ostor, Andrew ;
Raza, Karim ;
Taylor, Peter C. ;
van Schaardenburg, Dirkjan ;
Shivapatham, Dharshene ;
Wright, Alison J. ;
Vasconcelos, Joana C. ;
Kelly, Joanna ;
Murphy, Caroline ;
Prevost, A. Toby ;
Cope, Andrew P. .
TRIALS, 2019, 20 (1)
[3]  
[Anonymous], 1940, Acta Pathol Microbiol Scand
[4]   Rheumatic Manifestations of Cancer [J].
Ashouri, Judith F. ;
Daikh, David I. .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2011, 37 (04) :489-+
[5]   B cell targeted therapies in autoimmune disease [J].
Barnas, Jennifer L. ;
Looney, Richard John ;
Anolik, Jennifer H. .
CURRENT OPINION IN IMMUNOLOGY, 2019, 61 :92-99
[6]   Prognosis of Seronegative Patients in a Large Prospective Cohort of Patients with Early Inflammatory Arthritis [J].
Barra, Lillian ;
Pope, Janet E. ;
Orav, John E. ;
Boire, Gilles ;
Haraoui, Boulos ;
Hitchon, Carol ;
Keystone, Edward C. ;
Thorne, J. Carter ;
Tin, Diane ;
Bykerk, Vivian P. .
JOURNAL OF RHEUMATOLOGY, 2014, 41 (12) :2361-2369
[7]   Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset [J].
Berglin, E ;
Johansson, T ;
Sundin, U ;
Jidell, E ;
Wadell, G ;
Hallmans, G ;
Rantapää-Dahlqvist, S .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (04) :453-458
[8]   Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis [J].
Burkhardt, H ;
Sehnert, B ;
Bockermann, R ;
Engström, Å ;
Kalden, JR ;
Holmdahl, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) :1643-1652
[9]   The W620 Polymorphism in PTPN22 Disrupts Its Interaction With Peptidylarginine Deiminase Type 4 and Enhances Citrullination and NETosis [J].
Chang, Hui-Hsin ;
Dwivedi, Nishant ;
Nicholas, Anthony P. ;
Ho, I-Cheng .
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (09) :2323-2334
[10]  
clinicaltrials, CT2 SHOW NCT02603146